The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Acceleron Pharma Inc Common Stock 00434H108 95,240 2,803,645 SH   SOLE   2,803,645 0 0
Alimera Sciences Inc Common Stock 016259103 18,827 3,148,355 SH   SOLE   3,148,355 0 0
Cerulean Pharma Inc Common Stock 15708Q105 8,337 1,437,441 SH   SOLE   1,437,441 0 0